Monoclonal Antibodies in Veterinary Health Market
The Monoclonal Antibodies in Veterinary Health Market is rapidly evolving as the use of monoclonal antibody (mAb) therapies expands from human medicine into veterinary applications. These therapies are designed to target specific pathogens, cells, or proteins in animals, providing targeted and effective treatments with minimal side effects. The market is gaining traction due to the increasing incidence of chronic diseases in companion and livestock animals, as well as heightened awareness among pet owners and livestock producers about advanced treatment options.
Monoclonal antibodies (mAbs) in veterinary health are lab-generated antibodies designed to target specific antigens in animals, providing precise treatments for various diseases. Unlike traditional drugs, which may have broad effects and cause more side effects, mAbs are highly targeted, allowing them to bind to specific proteins, cells, or pathogens in the animal’s body. This makes them effective for treating conditions such as allergies, cancers, and infectious diseases with fewer side effects.
The Monoclonal Antibodies in Veterinary Health Market was valued at approximately USD 400 million in 2022 and is projected to reach around USD 1.1 billion by 2030, with an estimated compound annual growth rate (CAGR) of about 13-14% during the forecast period. This growth is largely driven by increasing demand for advanced treatments for chronic diseases in animals, rising pet ownership, and advancements in veterinary biotechnology.
| Report Attributes | Details |
| Study Period | 2023 to 2033 |
| Base Year | 2023 |
| FORECAST PERIOD | 2024-2030 |
| HISTORICAL PERIOD | 2020-2023 |
| UNIT | Value (USD Billion) |
| KEY COMPANIES PROFILED | Zoetis Merck & Co, Inc. Elanco Boehringer Ingelheim GmbH Indian Immunologicals Ltd Virbac |
| SEGMENTS COVERED | By Type, By Application, and By Geography |
| CUSTOMIZATION SCOPE | Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
How Monoclonal Antibodies Work
Monoclonal antibodies are produced by cloning a single immune cell, which creates identical antibodies that target one specific antigen. This specificity allows mAbs to:
Neutralize Pathogens: Bind to specific bacteria, viruses, or other pathogens, neutralizing them or marking them for destruction by the immune system.
Block Disease Pathways: Interfere with biological pathways that contribute to disease, such as those involved in inflammation or cancer.
Modulate the Immune System: Help regulate immune responses, reducing excessive reactions in conditions like arthritis or allergies.
Applications in Veterinary Health
Allergies and Skin Conditions: For example, Zoetis’ Cytopoint is a monoclonal antibody treatment that targets canine atopic dermatitis, reducing inflammation and itching by neutralizing a protein involved in the allergic response.
Cancer Therapy: mAbs are increasingly explored for veterinary oncology, where they can specifically target cancer cells, helping reduce the spread or growth of tumors.
Infectious Diseases: Used to combat diseases in livestock and companion animals, monoclonal antibodies can reduce reliance on antibiotics and prevent infections, improving health and productivity.
Benefits Over Traditional Treatments
Monoclonal antibodies provide several advantages, including:
Reduced Side Effects: Targeted action limits off-target effects, making treatments safer.
Single-Dose Effectiveness: Some mAb therapies offer long-lasting relief with a single dose, especially useful in chronic conditions.
Reduced Antibiotic Resistance: By providing alternative treatments for bacterial infections, mAbs help reduce antibiotic usage and the associated risk of resistance.
Challenges and Future Potential
The development of mAbs for veterinary use is costly and requires significant research and regulatory approval, which can limit accessibility. However, with growing interest in high-quality animal care and advances in biotechnology, mAb therapies are expected to expand in both companion and livestock animal care, promising new solutions for animal health management and chronic disease treatment.
Key Market Drivers
Rising Incidence of Animal Diseases: Conditions such as arthritis, allergies, cancer, and infectious diseases in animals have seen an increase, driving demand for targeted therapies. Monoclonal antibodies offer effective alternatives to traditional treatments, especially for chronic diseases.
Increasing Pet Ownership and Spending: As pet ownership continues to grow, particularly in urban areas, so does expenditure on advanced veterinary care. Pet owners are more willing to invest in high-quality treatments, including mAbs, to improve their pets’ health and quality of life.
Advances in Veterinary Medicine: Research in veterinary immunology and biotechnology has enabled the development of mAbs that can precisely target pathogens or cancer cells, making these therapies more effective and expanding their use.
Market Segmentation
The market can be segmented by species type, application, distribution channel, and region:
By Species Type: The main categories are companion animals (dogs and cats) and livestock animals (cattle, sheep, pigs). Companion animals make up the largest share due to high expenditure by pet owners on advanced treatments.
By Application: The primary applications include oncology, dermatology, pain management, and infectious diseases. mAbs are increasingly used to treat conditions like canine atopic dermatitis and mast cell tumors.
By Distribution Channel: Veterinary hospitals, clinics, and online pharmacies represent the main channels for these therapies. Veterinary hospitals dominate due to the availability of specialized care and diagnostic facilities.
By Region: North America holds a significant share, driven by high pet ownership rates, robust healthcare infrastructure, and high awareness. Europe and Asia-Pacific are also key markets, with Asia-Pacific experiencing rapid growth due to rising disposable income and increased livestock production.
Key Challenges
High Development Costs: The production of monoclonal antibodies is complex and costly, which can lead to high treatment costs, limiting accessibility.
Regulatory and Approval Challenges: Stringent regulations and lengthy approval processes for veterinary drugs can delay market entry. Ensuring that treatments are safe for animal use requires thorough testing and compliance with regulatory standards.
Lack of Awareness: While awareness is growing, many regions still have limited knowledge of mAb therapies in veterinary care, especially in emerging markets.
Market Trends
Increased R&D Investment: Many companies are investing in R&D to develop more targeted and effective mAbs for veterinary applications. This trend is supported by collaborations between biotech firms and research institutions.
Expansion Beyond Companion Animals: While mAbs have been primarily used for companion animals, there is increasing interest in applications for livestock animals, especially for diseases that impact animal productivity and food security.
Collaborations with Veterinary Hospitals and Clinics: Companies are partnering with veterinary clinics and hospitals to increase product awareness and streamline distribution channels for mAb therapies.
Key Players
Leading companies in the veterinary mAb market include:
Zoetis Inc.: A pioneer in veterinary monoclonal antibodies, Zoetis has products targeting pain and inflammation in dogs, like Cytopoint for atopic dermatitis.
Elanco Animal Health: Elanco focuses on both companion and livestock animals and is investing in expanding its portfolio of biologics, including mAb therapies.
Merck Animal Health: Known for a wide range of veterinary products, Merck is expanding into mAb therapies, especially for oncology and chronic diseases.
Boehringer Ingelheim: This company focuses on innovative therapies and has a strong veterinary medicine division, working on mAb products for both pets and livestock.
Future Outlook
The global monoclonal antibodies in veterinary health market is expected to grow at a compound annual growth rate (CAGR) in the high single to double digits through 2030, driven by increased pet ownership, technological advancements, and expansion into livestock applications. As costs decrease with more efficient production techniques and awareness rises, the adoption of mAb therapies in veterinary health is projected to increase steadily.
Monoclonal Antibodies in Veterinary Health Market Segments
By Animal Type
Dogs
Others
By Application
Dermatology
Pain
Others
By End-User
Veterinary Hospitals
Others
Monoclonal Antibodies in Veterinary Health Market Players
Zoetis
Merck & Co, Inc.
Elanco
Boehringer Ingelheim GmbH
Indian Immunologicals Ltd
Virbac
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. General Methodology
1.5. Research Scope & Assumptions
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Bottom-Up & Hybrid Model
1.7.3. CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Industry Analysis
3.3.1. Porter’s
3.3.2. PESTEL
3.4. Regulatory Framework
3.5. Product Pipeline Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Monoclonal Antibodies In Veterinary Health Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, USD Million, 2022 & 2030
4.3. Dogs
4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Others
4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Monoclonal Antibodies In Veterinary Health Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, USD Million, 2022 & 2030
5.3. Dermatology Market
5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Pain
5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Monoclonal Antibodies In Veterinary Health Market: End-User Estimates & Trend Analysis
6.1. Monoclonal Antibodies In Veterinary Health Market: End-User Movement Analysis, USD Million, 2022 & 2030
6.2. Veterinary Hospitals
6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Others
6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Monoclonal Antibodies In Veterinary Health Market: Regional Estimates & Trend Analysis
7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.4. Japan
7.4.4.1. Key Country Dynamics
7.4.4.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East & Africa
7.6.1. SWOT Analysis
7.6.2. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participation Categorization
8.2. Key Company Profiles
8.2.1 Zoetis
8.2.2 Merck & Co, Inc.
8.2.3 Elanco
8.2.4 Boehringer Ingelheim GmbH
8.2.5 Indian Immunologicals Ltd
8.2.6 Virbac
8.2.6.1. Participant’s Overview
8.2.6.2. Product Benchmarking
8.2.6.3. Financial Performance
8.2.6.4. Strategy Mapping
8.3. List of Other Players (inclusive of companies with pipeline products)
List of Tables
Table 1 Global Monoclonal Antibodies in Veterinary Health Market, by Region, 2018 - 2030 (USD Million)
Table 2 North America Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 3 North America Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 4 North America Monoclonal Antibodies In Veterinary Health Market, by Application
Table 5 North America Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 6 US Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 7 US Monoclonal Antibodies In Veterinary Health Market, by Application
Table 8 US Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 9 Canada Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 10 Canada Monoclonal Antibodies In Veterinary Health Market, by Application
Table 11 Canada Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 12 Europe Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 13 Europe Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 14 Europe Monoclonal Antibodies In Veterinary Health Market, by Application
Table 15 Europe Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 16 Germany Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 17 Germany Monoclonal Antibodies In Veterinary Health Market, by Application
Table 18 Germany Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 19 UK Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 20 UK Monoclonal Antibodies In Veterinary Health Market, by Application
Table 21 UK Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 22 Spain Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 23 Spain Monoclonal Antibodies In Veterinary Health Market, by Application
Table 24 Spain Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 25 Italy Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 26 Italy Monoclonal Antibodies In Veterinary Health Market, by Application
Table 27 Italy Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 28 France Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 29 France Monoclonal Antibodies In Veterinary Health Market, by Application
Table 30 France Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 31 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 32 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 33 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Application
Table 34 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 35 Japan Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 36 Japan Monoclonal Antibodies In Veterinary Health Market, by Application
Table 37 Japan Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 38 China Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 39 China Monoclonal Antibodies In Veterinary Health Market, by Application
Table 40 China Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 41 India Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 42 India Monoclonal Antibodies In Veterinary Health Market, by Application
Table 43 India Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 44 Australia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 45 Australia Monoclonal Antibodies In Veterinary Health Market, by Application
Table 46 Australia Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 47 South Korea Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 48 South Korea Monoclonal Antibodies In Veterinary Health Market, by Application
Table 49 South Korea Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 50 LATAM Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 51 LATAM Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 52 LATAM Monoclonal Antibodies In Veterinary Health Market, by Application
Table 53 LATAM Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 54 Brazil Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 55 Brazil Monoclonal Antibodies In Veterinary Health Market, by Application
Table 56 Brazil Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 57 Mexico Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 58 Mexico Monoclonal Antibodies In Veterinary Health Market, by Application
Table 59 Mexico Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 60 Argentina Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 61 Argentina Monoclonal Antibodies In Veterinary Health Market, by Application
Table 62 Argentina Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 63 MEA Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 64 MEA Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 65 MEA Monoclonal Antibodies In Veterinary Health Market, by Application
Table 66 MEA Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 67 South Africa Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 68 South Africa Monoclonal Antibodies In Veterinary Health Market, by Application
Table 69 South Africa Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 70 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 71 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Application
Table 72 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 73 Participant’s overview
Table 74 Financial performance
Table 75 Product Benchmarking
Table 76 Key companies undergoing strategies
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Monoclonal Antibodies in Veterinary Health Market segmentation
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 12 Porter’s five forces analysis
Fig. 13 Ansoff’s matrix analysis
Fig. 14 Heat map analysis
Fig. 15 Market penetration vs growth prospect mapping
Fig. 16 Market share of key market players- Monoclonal Antibodies in Veterinary Health Market
Fig. 17 Strategy mapping
Fig. 18 Monoclonal Antibodies in Veterinary Health Market animal type outlook: 2022
Fig. 19 Monoclonal Antibodies in Veterinary Health Market: animal type movement analysis
Fig. 20 Dogs market, 2018 - 2030 (USD Million)
Fig. 21 Others market, 2018 - 2030 (USD Million)
Fig. 22 Monoclonal Antibodies in Veterinary Health Market application outlook: 2022
Fig. 23 Monoclonal Antibodies in Veterinary Health Market: application movement analysis
Fig. 24 Dermatology market, 2018 - 2030 (USD Million)
Fig. 25 Pain market, 2018 - 2030 (USD Million)
Fig. 26 Others market, 2018 - 2030 (USD Million)
Fig. 27 Monoclonal Antibodies in Veterinary Health Market end-user outlook: 2022
Fig. 28 Monoclonal Antibodies in Veterinary Health Market: end-user movement analysis
Fig. 29 Veterinary Hospitals market, 2018 - 2030 (USD Million)
Fig. 30 Others market, 2018 - 2030 (USD Million)
Fig. 31 Regional marketplace: 2022
Fig. 32 Regional outlook, 2018 & 2030
Fig. 33 North America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 34 U.S. Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 35 Canada Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 36 Europe Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 37 UK Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 38 Germany Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 39 France Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 40 Italy Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 41 Spain Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 43 Japan Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 44 China Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 45 India Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 46 Australia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 47 South Korea Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 48 Latin America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 49 Brazil Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 50 Mexico Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 51 Argentina Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 52 MEA Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 53 South Africa Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 55 Strategy framework
Fig. 56 Market participant categorization
Monoclonal Antibodies in Veterinary Health Market Segments
By Animal Type
Dogs
Others
By Application
Dermatology
Pain
Others
By End-User
Veterinary Hospitals
Others
Monoclonal Antibodies in Veterinary Health Market Players
Zoetis
Merck & Co, Inc.
Elanco
Boehringer Ingelheim GmbH
Indian Immunologicals Ltd
Virbac
